Clinical Trials in New York
Here are the 6 most popular medical studies in New York Clinical Trials
Device Validation Using Blood Samples for Thrombotic Thrombocytopenic Purpura
Recruiting0 awards
New York, New York
This trial is for a new device that needs to be validated with known samples. 3 ml of blood is needed from people diagnosed with hTTP. You will be compensated for your time and resources.
Mucolytic Agent
N-acetylcysteine for Lupus
Recruiting0 awardsPhase 2
New York, New York
This trial is a phase II study to test the safety and efficacy of N-acetyl cysteine (NAC) in treating systemic lupus erythematosus (SLE). SLE is a chronic inflammatory disease which often has debilitating and potentially life-threatening consequences. The cause of SLE is unknown and current therapies lack specificity and carry significant side-effects. This study will have two groups of 105 subjects each, with one group continuing the tolerated dosage of NAC and the other group switched to placebo capsules. The study will last 13 months with seven study visits per subject. Each subject will donate approximately 100 ml of blood
Neuromuscular Blocker
Rocuronium + Remifentanil for Surgical Anesthesia
Recruiting3 awards
New York, New York
This trial is designed to study the effects of different doses of the medication rocuronium on patients undergoing surgery with general anesthesia. Researchers will be monitoring patients' vital signs and levels of muscle relaxation throughout the surgery and afterwards to see how well the rocuronium works.
Popular filter options for New York Clinical Trials trials
Phase 3 Clinical Trials
View 80 phase 3 medical studies.
Alkylating agents
Combination Chemotherapy for Ewing's Sarcoma
Recruiting4 awardsPhase 3
New York, New York
This trial is studying different combination chemotherapy regimens to see how well they work when given with or without peripheral stem cell transplantation, radiation therapy, and/or surgery in treating patients with Ewing's sarcoma.
Cancer Vaccine
Botanical Supplement for Lung Cancer
Recruiting1 awardPhase 3
New York, New York
This trial is testing whether a dietary supplement consisting of botanicals with known anti-cancer and/or immune-enhancing properties can prolong the survival time of stage IIIB/IV non-small cell lung cancer patients. The supplement will be given to patients in a double-blind fashion, meaning that neither the patients nor the trial staff will know who is receiving the supplement and who is receiving a placebo.
Clinical Trials With No Placebo
View 80 medical studies that do not have a placebo group.
Alkylating agents
Combination Chemotherapy for Ewing's Sarcoma
Recruiting4 awardsPhase 3
New York, New York
This trial is studying different combination chemotherapy regimens to see how well they work when given with or without peripheral stem cell transplantation, radiation therapy, and/or surgery in treating patients with Ewing's sarcoma.
Alkylating agents
Surgery + Chemotherapy + IMRT for Mesothelioma
Recruiting1 awardPhase 2
Middletown, New Jersey
This trial is testing a new, safer radiation therapy for people with a certain type of lung cancer. The old radiation therapy had lots of side effects, but the new one specifically targets the cancer and reduces the risk of damaging healthy tissue.
Anti-microtubule agent
Intravesical Abraxane for Bladder Cancer
Recruiting3 awardsPhase 1 & 2
New York, New York
This trial is designed to test the safety, toxicity, and efficacy of Abraxane for the treatment of recurrent transitional cell cancer of the urinary bladder. The trial will enroll a maximum of 18 patients in 3 cohorts. Dose increases will occur in groups of three patients, with each successive group receiving an increased concentration of Abraxane intravesically. No dose increase will occur until each member of the previous cohort has undergone the first instillation of the medication without experiencing a dose-limiting toxicity (DLT). The trial will be considered a successful if at any point in the study, there have been a total of 6 or more successes.
View More New York Clinical Trials Trials
See another 64 medical studies focused on New York Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.